Patents by Inventor Haiqiang Zeng

Haiqiang Zeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS
    Publication number: 20230002388
    Abstract: The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by nuclear SET domain-containing protein 2 (NSD2).
    Type: Application
    Filed: May 9, 2022
    Publication date: January 5, 2023
    Inventors: Haibing DENG, Jinbiao LIU, Counde OYANG, Ce WANG, Qitao XIAO, Guoliang XUN, Haiqiang ZENG
  • Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents
    Patent number: 11420970
    Abstract: The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by nuclear SET domain-containing protein 2 (NSD2).
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: August 23, 2022
    Assignee: NOVARTIS AG
    Inventors: Haibing Deng, Jinbiao Liu, Counde Oyang, Ce Wang, Qitao Xiao, Guoliang Xun, Haiqiang Zeng